Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 7 (2010), Issue 3 (March)

1. Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6.
   Am J Surg Pathol, 34(3): 341-54. [Abstract] [Full-text]
2. Differential expression and cellular distribution of gamma-tubulin and betaIII-tubulin in medulloblastomas and human medulloblastoma cell lines.
   J Cell Physiol, 223(2): 519-29. [Abstract] [Full-text]
3. Marker-independent identification of glioma-initiating cells.
   Nat Methods, 7(3): 224-8. [Abstract] [Full-text]
4. Palliative care of children with brain tumors: a parental perspective.
   Arch Pediatr Adolesc Med, 164(3): 225-30. [Abstract] [Full-text]
5. Pediatric epileptogenic gangliogliomas: seizure outcome and surgical results.
   J Neurosurg Pediatr, 5(3): 271-6. [Abstract] [Full-text]
6. Pediatric brain tumors: genetics and clinical outcome.
   J Neurosurg Pediatr, 5(3): 263-70. [Abstract] [Full-text]
7. Endoscopic biopsy of brain tumors in children: diagnostic success and utility in guiding treatment strategies.
   J Neurosurg Pediatr, 5(3): 255-62. [Abstract] [Full-text]
8. Coincidence of cervical spondylotic myelopathy and intramedullary ependymoma: a potential diagnostic pitfall.
   J Neurosurg Spine, 12(3): 249-52. [Abstract] [Full-text]
9. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.
   J Clin Invest, 120(3): 694-705. [Abstract] [Full-text]
10. Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas.
    J Clin Invest, 120(3): 663-7. [Abstract] [Full-text]
11. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Acta Radiol, 51(3): 316-25. [Abstract] [Full-text]
12. Students with brain tumors: their post-treatment perceptions of teachers, peers, and academics and retrospective views on school during treatment.
    J Child Health Care, 14(1): 111-25. [Abstract] [Full-text]
13. Increasing high-frequency oscillations (HFOs) in patients with brain tumours: implication for increasing amplitude of N20.
    Clin Neurophysiol, 121(4): 474-81. [Abstract] [Full-text]
14. Early expansion of the intracranial CSF volume after palliative whole-brain radiotherapy: results of a longitudinal CT segmentation analysis.
    Int J Radiat Oncol Biol Phys, 76(4): 1171-6. [Abstract] [Full-text]
15. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas.
    Int J Radiat Oncol Biol Phys, 76(4): 1177-84. [Abstract] [Full-text]
16. Evaluation of O-(2-[18F]-Fluoroethyl)-L-Tyrosine in the Diagnosis of Glioblastoma.
    Arch Neurol, 67(3): 370-2. [Abstract] [Full-text]
17. Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study.
    Arch Neurol, 67(3): 343-6. [Abstract] [Full-text]
18. Morphological characteristics of brain tumors causing seizures.
    Arch Neurol, 67(3): 336-42. [Abstract] [Full-text]
19. A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.
    Arch Neurol, 67(3): 313-9. [Abstract] [Full-text]
20. Bevacizumab for malignant gliomas.
    Arch Neurol, 67(3): 285-8. [Abstract] [Full-text]
21. Recent advances in therapy for glioblastoma.
    Arch Neurol, 67(3): 279-83. [Abstract] [Full-text]
22. Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets.
    J Clin Oncol, 28(8): 1337-44. [Abstract] [Full-text]
23. Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: a role in innate immunity?
    J Neuroimmunol, 220(1): 131-5. [Abstract] [Full-text]
24. Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells.
    Biochem Pharmacol, 79(10): 1516-25. [Abstract] [Full-text]
25. A 31-year-old woman with a transformed low-grade glioma.
    JAMA, 303(10): 967-76. [Abstract] [Full-text]
26. 99mTc-sestamibi scan differentiates tumor from other contrast enhancing tissue in choroid plexus tumors.
    J Pediatr Hematol Oncol, 32(2): 160-2. [Abstract] [Full-text]
27. Double high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation for primary disseminated medulloblastoma: a report of 3 cases.
    J Pediatr Hematol Oncol, 32(2): e70-4. [Abstract] [Full-text]
28. Medulloblastoma harbor somatic mitochondrial DNA mutations in the D-loop region.
    J Pediatr Hematol Oncol, 32(2): 156-9. [Abstract] [Full-text]
29. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement.
    Cancer, 116(6): 1545-52. [Abstract] [Full-text]
30. A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas.
    Virchows Arch, 456(3): 287-300. [Abstract] [Full-text]
31. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.
    Mol Cell, 37(5): 620-32. [Abstract] [Full-text]
32. GABAA receptor subunit beta1 is involved in the formation of protease-resistant prion protein in prion-infected neuroblastoma cells.
    FEBS Lett, 584(6): 1193-8. [Abstract] [Full-text]
33. Diffuse central nervous system protoplasmic astrocytoma.
    Pediatr Blood Cancer, 54(5): 768-9. [Abstract] [Full-text]
34. Synthesis and analysis of 2-[211At]-L-phenylalanine and 4-[211At]-L-phenylalanine and their uptake in human glioma cell cultures in-vitro.
    Appl Radiat Isot, 68(6): 1060-5. [Abstract] [Full-text]
35. Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma.
    Cancer Res, 70(6): 2548-57. [Abstract] [Full-text]
36. CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.
    Cancer Res, 70(6): 2455-64. [Abstract] [Full-text]
37. Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children.
    Cancer Chemother Pharmacol, 65(6): 1173-89. [Abstract] [Full-text]
38. In vivo imaging of MSCT and micro-CT: a comparison.
    Rofo, 182(4): 322-6. [Abstract] [Full-text]
39. The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.
    Br J Cancer, 102(6): 1052-60. [Abstract] [Full-text]
40. Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experience.
    Br J Cancer, 102(6): 995-1002. [Abstract] [Full-text]
41. Pharmacological treatment of depression in patients with a primary brain tumour.
    Cochrane Database Syst Rev, 3: CD006932. [Abstract] [Full-text]
42. FDG-PET/CT findings of a metastatic pituitary tumor.
    Cancer Imaging, 10: 114-6. [Abstract] [Full-text]
43. High chromosomal instability in brain metastases of colorectal carcinoma.
    Cancer Genet Cytogenet, 198(1): 47-51. [Abstract] [Full-text]
44. Radiation immunomodulatory gene tumor therapy of rats with intracerebral glioma tumors.
    Radiat Res, 173(4): 433-40. [Abstract] [Full-text]
45. Radiotherapy enhances antitumor effect of anti-CD137 therapy in a mouse Glioma model.
    Radiat Res, 173(4): 426-32. [Abstract] [Full-text]
46. Fractionated stereotactic radiotherapy in patients with acromegaly: an interim single-centre audit.
    Eur J Endocrinol, 162(4): 685-94. [Abstract] [Full-text]
47. Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease.
    Eur J Endocrinol, 162(4): 677-84. [Abstract] [Full-text]
48. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas.
    Oncogene, 29(12): 1845-56. [Abstract] [Full-text]
49. Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial.
    Eur J Endocrinol, 162(4): 661-6. [Abstract] [Full-text]
50. Comparing radiation treatments using intensity-modulated beams, multiple arcs, and single arcs.
    Int J Radiat Oncol Biol Phys, 76(5): 1554-62. [Abstract] [Full-text]
51. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: a feasibility study using volumetric modulated arc therapy.
    Int J Radiat Oncol Biol Phys, 76(5): 1480-5. [Abstract] [Full-text]
52. Stereotactic radiosurgery in the management of brain metastases: an institutional retrospective analysis of survival.
    Int J Radiat Oncol Biol Phys, 76(5): 1486-92. [Abstract] [Full-text]
53. On the importance of accounting for competing risks in pediatric cancer trials designed to delay or avoid radiotherapy: I. Basic concepts and first analyses.
    Int J Radiat Oncol Biol Phys, 76(5): 1493-9. [Abstract] [Full-text]
54. Clinical evaluation of stereotactic target localization using 3-Tesla MRI for radiosurgery planning.
    Int J Radiat Oncol Biol Phys, 76(5): 1472-9. [Abstract] [Full-text]
55. Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas.
    Cancer, 116(7): 1776-82. [Abstract] [Full-text]
56. Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival.
    Int J Cancer, 126(10): 2341-52. [Abstract] [Full-text]
57. Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas.
    Int J Cancer, 126(10): 2282-95. [Abstract] [Full-text]
58. Reversible cerebrospinal fluid edema and porencephalic cyst, a rare complication of ventricular catheter.
    J Clin Neurosci, 17(5): 658-61. [Abstract] [Full-text]
59. Cavernoma in the pineal region.
    J Clin Neurosci, 17(5): 652-3. [Abstract] [Full-text]
60. Fatal epistaxis from the fetal posterior communicating artery--a delayed complication of trans-sphenoidal surgery.
    J Clin Neurosci, 17(5): 656-8. [Abstract] [Full-text]
61. Pathological crying as a manifestation of spontaneous haemorrhage in a pontine cavernous haemangioma.
    J Clin Neurosci, 17(5): 662-3. [Abstract] [Full-text]
62. A rare paraganglioma with skull and brain metastasis.
    J Clin Neurosci, 17(5): 644-6. [Abstract] [Full-text]
63. The effects of EEG suppression and anesthetics on stimulus thresholds in functional cortical motor mapping.
    Clin Neurophysiol, 121(5): 784-92. [Abstract] [Full-text]
64. The association between birth order, sibship size and glioma development in adulthood.
    Int J Cancer, 126(11): 2752-6. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.